Table 3.
Africa | The Gambia | Mali | Mozambique | Kenya | Asia | India | Bangladesh | Pakistan | |
---|---|---|---|---|---|---|---|---|---|
No. of casesa | 100 | 15 | 2 | 5 | 78 | 90 | 5 | 42 | 43 |
No antibiotics prescribed/given, n (%) | 23 (23.0) | 4 (26.7) | 0 | 0 | 19 (24.4) | 36 (40.0) | 0 | 1 (2.4) | 35 (81.4) |
Any antibiotics prescribed/given, n (%) | 77 (77.0) | 11 (73.3) | 2 (100) | 5 (100) | 59 (75.6) | 54 (60.0) | 5 (100) | 41 (97.6) | 8 (18.6) |
Antimicrobial agent, n (%) | |||||||||
Ampicillinb | 1 (1.0) | 0 | 0 | 1 (20.0) | 0 | 0 | 0 | 0 | 0 |
Chloramphenicolb | 6 (6.0) | 3 (20.0) | 0 | 3 (60.0) | 0 | 0 | 0 | 0 | 0 |
Ciprofloxacin/other fluoroquinoloneb | 5 (5.0) | 1 (6.7) | 0 | 0 | 4 (5.1) | 43 (47.8) | 4 (80.0) | 31 (73.8) | 8 (18.6) |
Trimethoprim/sulfamethoxazoleb | 59 (59.0) | 8 (53.3) | 2 (100) | 1 (20.0) | 48 (61.5) | 6 (6.7) | 1 (20.0) | 5 (11.9) | 0 |
Gentamicinb | 12 (12.0) | 0 | 0 | 2 (40.0) | 10 (12.8) | 0 | 0 | 0 | 0 |
Amoxicillin | 4 (4.0) | 1 (6.7) | 0 | 1 (20.0) | 2 (2.6) | 0 | 0 | 0 | 0 |
Azithromycin | 0 | 0 | 0 | 0 | 0 | 4 (4.4) | 0 | 4 (9.5) | 0 |
Erythromycin | 1 (1.0) | 0 | 0 | 0 | 1 (1.3) | 1 (1.1) | 0 | 1 (2.4) | 0 |
Penicillin | 9 (9.0) | 0 | 0 | 2 (40.0) | 7 (9.0) | 0 | 0 | 0 | 0 |
Selexid/pivmecillinam | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other macrolides | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Abbreviation: GEMS, Global Enteric Multicenter Study.
aTotal number of cases with moderate-to-severe diarrhea who were prescribed or given any antimicrobial agent at any participating sentinel health facility.
bAntimicrobial agents that were tested for susceptibility.